Literature DB >> 23676170

Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay.

L Guglielmetti1, A Cazzadori, M Conti, F Boccafoglio, A Vella, R Ortolani, E Concia.   

Abstract

Cell-mediated immune response plays an essential role in the pathogenesis of tuberculosis (TB). We retrospectively evaluated lymphocyte subpopulations in 177 active TB patients compared to 93 healthy controls, finding a relevant decrease in total lymphocytes and CD8+ cells. Conversely, activated human leukocyte antigen (HLA-DR+) and CD4+CD57+ cells were higher in the TB group. B-1a (CD5+CD19+) lymphocytes were reduced in TB subjects, particularly those with extended and cavitary pulmonary forms, suggesting increased compartmentalisation at the infection site. QuantiFERON-TB Gold In-Tube positive results were associated with higher HLA-DR+CD4+ and CD4+CD57+ cells, while interferon-gamma response and total lymphocyte levels were lower in advanced pulmonary TB cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676170     DOI: 10.5588/ijtld.12.0361

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study.

Authors:  Selvakumar Subbian; Liana Tsenova; Mi-Jeong Kim; Helen C Wainwright; Annalie Visser; Nirmalya Bandyopadhyay; Joel S Bader; Petros C Karakousis; Gabriele B Murrmann; Linda-Gail Bekker; David G Russell; Gilla Kaplan
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

2.  Combining interferon-γ release assays with lymphocyte enumeration for diagnosis of Mycobacterium tuberculosis infection.

Authors:  Dingfeng Lv; Yanqing Liu; Fei Guo; Aihua Wu; Yijun Mo; Shanshan Wang; Jinguo Chu
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

3.  The relationship between absolute counts of lymphocyte subsets and clinical features in patients with pulmonary tuberculosis.

Authors:  Hui-Ru An; Xue-Juan Bai; Jian-Qin Liang; Tao Wang; Zhong-Yuan Wang; Yong Xue; Yin-Ping Liu; Lan Wang; Xue-Qiong Wu
Journal:  Clin Respir J       Date:  2022-05-06       Impact factor: 1.761

4.  Unbalanced serum immunoglobulins in clinical subtypes of pediatric tuberculosis disease.

Authors:  Filippo Consonni; Nicolò Chiti; Silvia Ricci; Elisabetta Venturini; Clementina Canessa; Leila Bianchi; Francesca Lippi; Carlotta Montagnani; Mattia Giovannini; Elena Chiappini; Luisa Galli; Chiara Azzari; Lorenzo Lodi
Journal:  Front Pediatr       Date:  2022-08-09       Impact factor: 3.569

5.  Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience.

Authors:  Giulia Scioscia; Donato Lacedonia; Ernesto Giuffreda; Incoronata Caccavo; Carla Maria Irene Quarato; Piera Soccio; Pasquale Tondo; Ennio Vincenzo Sassani; Dalila Pescatore; Maria Pia Foschino Barbaro
Journal:  Front Med (Lausanne)       Date:  2022-09-07

6.  Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania.

Authors:  Tumaini J Nagu; Donna Spiegelman; Ellen Hertzmark; Said Aboud; Julie Makani; Mecky I Matee; Wafaie Fawzi; Ferdinand Mugusi
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

7.  Similar source of differential blood mRNAs in lung cancer and pulmonary inflammatory diseases: calls for improved strategy for identifying cancer-specific biomarkers.

Authors:  Guini Hong; Beibei Chen; Hongdong Li; Wenjing Zhang; Tingting Zheng; Shan Li; Tongwei Shi; Lu Ao; Zheng Guo
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.